Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.
D019485:Bone Morphogenetic Proteins / Q000378:metabolism / Q000502:physiology*; D001859:Bone Neoplasms / Q000378:metabolism / Q000473:pathology / Q000556:secondary; D002454:Cell Differentiation / Q000502:physiology; D045744:Cell Line, Tumor; D006801:Humans; D008297:Male; D010006:Osteoblasts / Q000473:pathology*; D011401:Promoter Regions, Genetic; D011471:Prostatic Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis* / Q000235:genetics
D019485:Bone Morphogenetic Proteins; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A